COVID Catalyst Awardees Announced!

 

Congratulations to our Covid Catalyst awardees for being selected for bridge funding for their high-risk, innovative, and important research on the Covid-19 pandemic.

Awardees by institution:

UC Berkeley

Kunxin Luo – High affinity soluble ACE2 decoy receptor approach for Covid-19

 

 

 

 

 

 

Russell Vance –  Targeting the inflammasome to combat Covid-19

 

 

 

 

Michael Rape –  Improving efficacy of remdesivir

 

 

 

 

 

Eva Harris – Cyclodextrin use to combat Covid-19

 

 

 

 

 

 

 

Sarah Stanley – Repurposing screen of approved compounds for Covid-19

 

 

 

 

UC Berkeley Drug Discovery Center – Central repository for reagents for Covid-19 research

 

 

 

 

 

 

Julia Walsh – Novel LAMP POC diagnostic for Covid-19

 

 

 

 

 

Michael Marletta – Nitric Oxide effects on Covid-19 infection

 

 

 

 

 

 

UC Davis

Richard Levenson –  Intranasal Chitosan for Covid-19

 

 

 

 

 

UC San Francisco

Paola Betancur – CD47 inhibition to combat Covid-19

 

 

 

 

 

Marcelle Cedars – Pregnancy outcomes and Covid

 

 

 

 

 

 

 

John Metcalfe – Covid outcomes in HIV patients

 

 

 

Bruce Wang – Cell types that get infected in patients during Covid-19

 

 

 

 

 

 

Charles Craik – Target based screen for Covid-19

 

 

 

Janet Wojcicki – Covid-19 in LatinX populations

 

 

 

 

 

UC Santa Cruz

Nader Pourmand – Novel POC diagnostic for Covid-19

 

 

 

 

 

Stanford

Brice Gaudilliere – Immune response characterization during Covid-19 infection

 

 

 

 

Taia Wang – Immune response characterization during Covid-19 infection

 

 

 

 

Jayakar Nayak – Iodine nasal spray to combat Covid-19 infection

 

 

 

 

Congratulations again to our awardees and we look forward to your exciting research!